Neutralization of the in vivo activity of E. coli-derived lipopolysaccharide by cationic peptides.
Brackett
D J
DJ
Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, USA.
Lerner
M R
MR
Pereira
H A
HA
D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D023181:Antimicrobial Cationic Peptides; D015306:Biogenic Monoamines / Q000097:blood; D002319:Cardiovascular System / Q000187:drug effects; D016207:Cytokines / Q000097:blood; D004926:Escherichia coli; D006439:Hemodynamics / Q000187:drug effects; D006632:Histamine / Q000097:blood; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008297:Male; D011506:Proteins / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D017207:Rats, Sprague-Dawley
D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; D015306:Biogenic Monoamines; D016207:Cytokines; D008070:Lipopolysaccharides; D011506:Proteins; D006632:Histamine